As of Friday close, Precigen Inc.’s (NASDAQ:PGEN) stock was down -$0.06, moving down -5.56 percent to $1.02. The average number of shares traded per day over the past five days has been 2,024,340 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0700 fall in that time frame. In the last twenty days, the average volume was 2,037,265, while in the previous 50 days, it was 2,403,182.
Since last month, PGEN stock retreated -32.45%. Shares of the company fell to $1.0000 on 03/17/23, the lowest level in the past month. A 52-week high of $2.90 was reached on 01/23/23 after having rallying from a 52-week low of $1.05. Since the beginning of this year, PGEN’s stock price has dropped by -32.89% or -$0.5000, and marked a new high 10 times. However, the stock has declined by -64.83% since its 52-week high.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
PGEN stock investors should be aware that Precigen Inc. (PGEN) stock had its last reported insider trading activity 50 days ago on Jan 27. KIRK RANDAL J, the Director of the company, purchased of 11,428,571 shares for $1.75 on Jan 27. It resulted in a $19,999,999 investment by the insider. Thomasian Harry Jr. added 28,571 shares at an average price of $1.75 on Jan 27. The insider now owns 84,961 shares following the transaction. On Jan 27, SVP, IP Affairs Perez Jeffrey Thomas bought 28,571 shares at $1.75 apiece. The transaction was valued at $49,999.
The stock’s beta is 1.98. Besides these, the trailing price-to-sales (P/S) ratio of 10.27, the price-to-book (PB) ratio of 1.62.
In the three months ended December 30, Precigen Inc.’s quick ratio stood at 1.50, while its current ratio was 1.50, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 76.40% percent. Based on annual data, PGEN earned $20.57 million in gross profit and brought in $26.91 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -44.60%. Return on equity (ROE) for the past 12 months was 28.40%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. PGEN’s revenue rose 197.86% to $16.72 million during the quarter, while net income inched up to -$24.75 million. While analysts expected Precigen Inc. to report -$0.1 quarterly earnings, the actual figure was -$0.11 per share. During the quarter, the company generated -$24.06 million in EBITDA. The liabilities of Precigen Inc. were 89.72 million at the end of its most recent quarter ended December 30, and its total debt was $51.42 million. The value of shareholders’ equity is $252.19 million.
This quick technical analysis looks at Precigen Inc.’s (PGEN) price momentum. With a historical volatility rate of 110.11%, the RSI 9-day stood at 28.33% on 17 March.
With respect to its five-day moving average, the current Precigen Inc. price is down by -6.42% percent or -$0.0700. At present, PGEN shares trade -26.09% below its 20-day simple moving average and -40.70% percent below its 100-day simple moving average. However, the stock is currently trading approximately -34.62% below its SMA50 and -23.88% below its SMA200.
Stochastic coefficient K was 9.29% and Stochastic coefficient D was 11.67%, while ATR was 0.1004. Given the Stochastic reading of 5.00% for the 14-day period, the RSI (14) reading has been calculated as 32.08%. As of today, the MACD Oscillator reading stands at -0.0756, while the 14-day reading stands at -0.0855.